Pharmafile Logo
Pharmafocus logo
Advanced Search
The ABPI has welcomed the announcement

Pharma thumbs-up for government innovation centre

September 12, 2012
Research and Development, Sales and Marketing ABPI, synthetic biology

The announcement of a new innovation and knowledge centre for synthetic biology has been welcomed by pharma groups.The new centre is part …

News
The RNAi therapeutic mechnism

New frontiers in drug discovery

September 11, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing RNA, drug discovery, therapeutic

Despite the success of small molecule and biologic drugs such as monoclonal antibodies, there remain many areas of unmet medical …

Feature
dr_brett_haumann

Circassia appoints GSK’s Dr Brett Haumann

September 11, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Brett Haumann, Circassia

Speciality biopharma firm Circassia has announced the appointment of Dr Brett Haumann as chief medical officer. Haumann joins allergy-focussed Circassia …

Appointment
Merck image

Merck releases new Phase III insomnia data

September 11, 2012
Research and Development, Sales and Marketing Merck, insomnia, suvorexant

Merck says it is on course to file its investigational insomnia drug suvorexant in the US by the end of …

News
Patheon image

Patheon offloads clinical packaging ops

September 11, 2012
Manufacturing and Production Bellwyck, Ontario, Patheon

Patheon has sold its global secondary clinical packaging and clinical distribution services business to Bellwyck Packaging Solutions as it continues …

News
Takeda HQ image

Takeda opens Russian manufacturing facility

September 11, 2012
Manufacturing and Production Actovegin, Nycomed, Russia, Takeda

Takeda Pharmaceutical has officially opened its new manufacturing facility in Yaroslavl, Russia, and expects it to be operating at full …

News

Rock appoints new associate director

September 11, 2012
Business Services, Medical Communications, Sales and Marketing Laura Patel, Rock Medical Communications

ROCK medical communications has appointed Laura Patel as associate director. Patel has considerable experience in managing key medical education programmes, …

Appointment
MedImmune

MedImmune signs China deal

September 11, 2012
Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, China, MedImmune, WuXi, emerging markets, rheumatoid arthritis

MedImmune has sealed a joint venture with Shanghai-based WuXi AppTec to develop a novel biologic for autoimmune and inflammatory diseases …

News
screen_shot_2012-09-10_at_10

Ex-Pfizer head joins Red Door as International director

September 10, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Andrew Thomas, Pfizer, Red Door

Andrew Thomas the strategic communications lead for Pfizer’s primary care medicines across Europe and Canada joins Red Door Communications in …

Appointment
lilly corporate hq image

Lilly suffers late-stage cancer blow

September 10, 2012
Research and Development, Sales and Marketing Alimta, Cancer, avastin, lilly, oncology

Eli Lilly suffered a blow to its oncology programme when a new combination treatment failed to improve overall survival in …

News
merck kgaa image

Merck KGaA licences new cancer candidate

September 10, 2012
Research and Development, Sales and Marketing Cancer, EGFR, Merck KGaA, oncology

Merck KGaA has signed a worldwide licence agreement with Danish company Symphogen which could expand its portfolio of drugs targeting …

News

Kantar appoints Graeme Jacombs head of APMEA region

September 7, 2012
Sales and Marketing Kantar Health

Consultancy and market research firm Kantar Health has promoted Graeme Jacombs to Managing Director of the Asia Pacific, Middle East …

Appointment

Boehringer signs diabetes research deal

September 7, 2012
Sales and Marketing Boehringer, diabetes, obesity

Boehringer Ingelheim has signed a four-year research agreement with a top Swiss university to look at the underlying causes of …

News

Novartis to file for new Lucentis indication

September 7, 2012
Lucentis, Novartis, macular edema, macular oedema, ophthamology

Novartis is set to file eye treatment Lucentis for a new indication. The firm will submit Lucentis (ranibizumab) to the …

News

New product launches – maximise your chance of success

September 6, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing MSI, Paul Stuart Kregor, Paul Stuart-Kregor, marketing, product launch

You don’t have to look very far to see that the pharma industry business model is under increased pressure, and …

Feature

Brazil delays excipient GMP deadline

September 6, 2012
Manufacturing and Production ANVISA, Brazil, GMP

Brazil’s national medicines regulatory agency ANVISA has delayed proposed new rules on good manufacturing practice (GMP) for pharmaceutical excipients after …

News

Hospira buys Indian antibiotic plant

September 6, 2012
Manufacturing and Production Hospira, India

US injectable drugs specialist Hospira has announced plans to expand in India via the purchase of a manufacturing facility and …

News
fda_sign_web

Double approval for Pfizer cancer drugs

September 6, 2012
Sales and Marketing CML, Cancer, Glivec, Pfizer, axitinib, rcc

 Two cancer drugs from Pfizer have been approved, one in Europe for kidney cancer and another in the US for …

News

Merck KGaA cuts over 10% of German workforce

September 5, 2012
Research and Development

Merck KGaA is to get rid of more than 10% of its workforce in Germany over the next three years …

News

Pharma welcomes Hunt to top health job

September 5, 2012
Research and Development, Sales and Marketing Andrew Lansley, NHS, NHS reform

The ABPI has used health secretary Andrew Lansley’s demotion at prime minister David Cameron’s first major cabinet reshuffle to restate …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026